📖

entities-gfap

wiki page Created: 2026-04-02T17:01:41 By: crosslink-v2 Quality: 50% ✓ SciDEX ID: wiki-entities-gfap
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (364)
mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring90%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation90%
related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation90%
mentions🧫iPSC-NPC effects on astrocytes in vitro ICH model80%
mentions🔬Neuroinflammation and microglial priming in early Alzheimer&75%
related🧫iPSC-NPC effects on astrocytes in vitro ICH model72%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation70%
mentions🧫GWAS of composite biomarker score70%
mentions🧫Plasma ATN biomarkers across AD continuum in Chilean cohort70%
mentions🧫Real-world safety study of Lecanemab in Japanese AD patients70%
mentions🧫iPSC-NPC transplantation in ICH animal model70%
mentions🧫GWAS of plasma GFAP in East Asian cohort70%
mentions🧫Proposed experiment from debate on Astrocytes adopt A1 (neur70%
mentions🧫s:** - ALOX15 overexpression in healthy astrocytes should be70%
mentions🧫Proposed experiment from debate on Epigenetic clocks and bio70%
mentions🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional70%
mentions🧫s:** - Dose-response studies showing therapeutic window with70%
mentions🧫Proposed experiment from debate on Microglia activate astroc70%
mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi70%
mentions🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti70%
mentions🧫Anti-Tau Immunotherapy Dosing Optimization70%
mentions🧫ApoE4 Function in Alzheimer's Disease70%
mentions🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&70%
mentions🧫Blood-Based Biomarker Panel for Early AD Detection70%
mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring70%
mentions🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M70%
mentions🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i70%
mentions🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera70%
mentions🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M70%
mentions🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation70%
mentions🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas70%
mentions🧫Neural Stem Cell Therapy for Alzheimer's Disease70%
mentions🧫Normal Aging to Alzheimer's Disease Transition Trigger 70%
mentions🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 70%
mentions🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G70%
mentions🧫PSP and CBS Biomarker Validation Study70%
mentions🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease70%
mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and70%
mentions🧫Traumatic Brain Injury and Alzheimer's Disease Relation70%
mentions🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal70%
related🧫Cytochrome Therapeutics70%
related🧫Cytochrome Therapeutics70%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring70%
see_also🧪GFAP-Positive Reactive Astrocyte Subtype Delineation70%
related🔬Neuroinflammation and microglial priming in early Alzheimer&67%
related🧫GWAS of composite biomarker score63%
related🧫Plasma ATN biomarkers across AD continuum in Chilean cohort63%
related🧫Real-world safety study of Lecanemab in Japanese AD patients63%
related🧫iPSC-NPC transplantation in ICH animal model63%
related🧫GWAS of plasma GFAP in East Asian cohort63%
related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur63%
related🧫s:** - ALOX15 overexpression in healthy astrocytes should be63%
related🧫Proposed experiment from debate on Epigenetic clocks and bio63%
related🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional63%
related🧫s:** - Dose-response studies showing therapeutic window with63%
related🧫Proposed experiment from debate on Microglia activate astroc63%
related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi63%
related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti63%
related🧫Anti-Tau Immunotherapy Dosing Optimization63%
related🧫ApoE4 Function in Alzheimer's Disease63%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&63%
related🧫Blood-Based Biomarker Panel for Early AD Detection63%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring63%
related🧫Cognitive Reserve Mechanisms in Alzheimer's Disease — M63%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i63%
related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera63%
related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M63%
related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation63%
related🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas63%
related🧫Neural Stem Cell Therapy for Alzheimer's Disease63%
related🧫Normal Aging to Alzheimer's Disease Transition Trigger 63%
related🧫CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs 63%
related🧫Presymptomatic GRN Carrier Intervention Timing — Biomarker-G63%
related🧫PSP and CBS Biomarker Validation Study63%
related🧫SCFA-Mediated Neuroinflammation in Alzheimer's Disease63%
related🧫Sex Differences in Alzheimer's Disease — mechanisms and63%
related🧫Traumatic Brain Injury and Alzheimer's Disease Relation63%
related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal63%
see_also📖PSD-95 (Postsynaptic Density Protein 95)60%
see_also📖adam1060%
see_also📖EEF2K — Eukaryotic Elongation Factor 2 Kinase60%
see_also📖JNK1 (MAPK8)60%
see_also📖NTF3 — Neurotrophin-360%
see_also📖RCAN1 Gene60%
see_also📖SMAD1 Gene60%
see_also📖SMAD2 Gene60%
see_also📖TLR6 Gene60%
see_also📖tnfaip360%
see_also📖Neurogranin (Ng) - Synaptic Biomarker60%
see_also📖ABCA7 (Redirect)60%
see_also📖ACTB Gene60%
see_also📖AIF1 Gene60%
see_also📖MYT1L Gene60%
see_also📖NCF1 — Neutrophil Cytosolic Factor 160%
see_also📖OLIG2 Gene60%
see_also📖OSMR Gene60%
see_also📖RPL24 — Ribosomal Protein L2460%
see_also📖RPS23 — Ribosomal Protein S2360%
see_also📖tpm260%
see_also📖Neurogranin-Guided Synapse Rescue Therapy60%
see_also📖Aging vs Neurodegeneration: Mechanistic Comparison Matrix60%
see_also📖Neurogranin (RC3)60%
see_also📖Neuronal Nitric Oxide Synthase60%
see_also📖Reactive Astrocytes (A2 Phenotype)60%
see_also📖Reactive Astrocytes in Neurodegeneration60%
see_also📖Reactive Astrocytes in Neuroinflammation60%
see_also📖IL16 Gene60%
see_also📖IL9 (Interleukin 9)60%
see_also📖NPTX1 — Neuronal Pentraxin 160%
see_also📖NPTX1 Protein60%
see_also📖ACSL4 Gene - Acyl-CoA Synthetase Long Chain Family Member 460%
see_also📖SCRIB Gene60%
see_also📖Excitotoxicity60%
see_also📖Hippocampus60%
see_also📖dlk260%
see_also📖LIF — Leukemia Inhibitory Factor60%
see_also📖LIFR - Leukemia Inhibitory Factor Receptor60%
see_also📖VGF — VGF Nerve Growth Factor Inducible60%
see_also📖VGF Nerve Growth Factor60%
see_also📖CHRNA6 Gene60%
see_also📖ELAVL3 Gene60%
see_also📖hes160%
see_also📖MAG Gene60%
see_also📖NOX2 Gene60%
see_also📖OLIG1 Gene60%
see_also📖PLP1 Gene60%
see_also📖RAB3B Gene60%
see_also📖NOX2/CYBB (NADPH Oxidase 2)60%
see_also📖RAB3B Protein60%
see_also📖Ubiquitin C-terminal Hydrolase L1 (UCH-L1)60%
see_also📖Ceftriaxone ALS Trial60%
see_also📖ACTG1 Gene60%
see_also📖ATP5A1 Gene60%
see_also📖cct260%
see_also📖JUND Gene - JunD Transcription Factor60%
see_also📖MT1A (Metallothionein-1A)60%
see_also📖NOS1 — Nitric Oxide Synthase 160%
see_also📖PSMA3 Gene60%
see_also📖SYNGR3 Gene60%
see_also📖UCHL1 Gene60%
see_also📖Ceftriaxone for Amyotrophic Lateral Sclerosis60%
see_also📖astrocyte-neuron-metabolic-coupling-parkinsons60%
see_also📖Astrocytes60%
see_also📖Neuroprotection Strategies in Neurodegeneration60%
see_also📖Hippocampal CA1 Pyramidal Neurons60%
see_also📖metformin-add-on-levodopa-pd-nct0705595860%
see_also📖biomarkers60%
see_also📖Biomarkers for Corticobasal Degeneration60%
see_also📖Biomarkers to Distinguish FTLD-tau from FTLD-TDP60%
see_also📖Biomarkers for Multiple System Atrophy60%
see_also📖Biomarkers for Progressive Supranuclear Palsy60%
see_also📖Biomarkers in Parkinsonian Syndromes (NCT06501469)60%
see_also📖4D Molecular Therapeutics60%
see_also📖Alzheimer's Digital Therapeutics Companies60%
see_also📖AD Exosome and Extracellular Vesicle Companies60%
see_also📖AD RNA-Based Therapeutics Companies60%
see_also📖Alectos Therapeutics Inc60%
see_also📖Aleza Therapeutics60%
see_also📖Alterity Therapeutics60%
see_also📖Amyl Therapeutics60%
see_also📖Appvian Therapeutics60%
see_also📖Arvinas Therapeutics60%
see_also📖Axial Therapeutics60%
see_also📖Axsome Therapeutics, Inc.60%
see_also📖BlueRock Therapeutics60%
see_also📖BrainStorm Cell Therapeutics Inc.60%
see_also📖Capricor Therapeutics60%
see_also📖Cerevel Therapeutics60%
see_also📖Chelsea Therapeutics60%
see_also📖Click Therapeutics60%
see_also📖Convelo Therapeutics60%
see_also📖CRISPR Therapeutics60%
see_also📖cyclo-therapeutics60%
see_also📖cynata-therapeutics60%
see_also📖Cytochrome Therapeutics60%
see_also📖Denali Therapeutics60%
see_also📖Encoded Therapeutics60%
see_also📖Evox Therapeutics60%
see_also📖Finch Therapeutics60%
see_also📖Fulcrum Therapeutics60%
see_also📖heqIX Therapeutics60%
see_also📖Iduna Therapeutics60%
see_also📖IFM Therapeutics60%
see_also📖Inception Therapeutics60%
see_also📖Karuna Therapeutics60%
see_also📖Koneqia Therapeutics60%
see_also📖Lexeo Therapeutics60%
see_also📖Lysoway Therapeutics60%
see_also📖Lyterian Therapeutics60%
see_also📖Monte Rosa Therapeutics60%
see_also📖Muna Therapeutics60%
see_also📖Neteo Therapeutics60%
see_also📖NeuBase Therapeutics60%
see_also📖NeuExo Therapeutics60%
see_also📖Neumora Therapeutics60%
see_also📖NeuroMito Therapeutics60%
see_also📖Paxos Therapeutics60%
see_also📖Parkinson's Disease Digital Therapeutics Companies60%
see_also📖pd-exosome-therapeutics60%
see_also📖PD RNA Therapeutics Companies60%
see_also📖Pear Therapeutics60%
see_also📖Pinteon Therapeutics60%
see_also📖Prevail Therapeutics60%
see_also📖Rodin Therapeutics60%
see_also📖Sage Therapeutics60%
see_also📖Sangamo Therapeutics60%
see_also📖Spark Therapeutics60%
see_also📖Spin Therapeutics60%
see_also📖Stoke Therapeutics60%
see_also📖Synaptic Therapeutics60%
see_also📖Synchronicity Therapeutics60%
see_also📖T3D Therapeutics60%
see_also📖Trefoil Therapeutics60%
see_also📖Vator Therapeutics Inc.60%
see_also📖Ventus Therapeutics60%
see_also📖Voyager Therapeutics60%
see_also📖VTV Therapeutics60%
see_also📖Yumanity Therapeutics60%
see_also📖MDS 2026 — Emerging Therapeutics in Parkinson's Disease60%
see_also📖alzheimers-disease60%
see_also📖Aleza Therapeutics60%
see_also📖Denali Therapeutics60%
see_also📖4R Tauopathy Therapeutics — Investment Landscape Analysis60%
see_also📖Adult Neurogenesis Therapeutics Investment Landscape60%
see_also📖Anti-Tau Therapeutics: Investment Landscape Analysis60%
see_also📖ER Stress & UPR Therapeutics Investment Landscape60%
see_also📖GLP-1 Receptor Agonist Therapeutics Investment Landscape60%
see_also📖Heat Shock Protein (HSP) Therapeutics for Neurodegeneration60%
see_also📖Lysosomal Dysfunction Therapeutics Investment Landscape60%
see_also📖Microbiome-Based Therapeutics for Neurodegeneration: Investm60%
see_also📖Mitochondrial Therapeutics Investment Landscape60%
see_also📖Peptide Therapeutics for Neurodegeneration — Investment Land60%
see_also📖Protein Aggregation Inhibitors for Neurodegeneration — Inves60%
see_also📖RNA Therapeutics: Investment Landscape Analysis60%
see_also📖Senolytic Therapeutics: Investment Landscape Analysis60%
see_also📖Anti-Amyloid Therapeutics: Successes, Failures, and Lessons 60%
see_also📖Biomarkers of Alzheimer Disease60%
see_also📖Biomarkers in Neurodegeneration60%
see_also📖Biomarkers for Parkinson's Disease60%
see_also📖Denali Therapeutics60%
see_also📖Digital Therapeutics for Neurodegenerative Diseases60%
see_also📖RNA Editing Therapeutics60%
see_also📖therapeutics60%
see_also📖Anti-Amyloid Therapeutics60%
see_also📖Anti-Tau Therapeutics60%
see_also📖Cyclophosphamide60%
see_also📖Exosome-Based Therapeutics for Neurodegenerative Diseases60%
see_also📖Mitochondrial Therapeutics60%
see_also📖Neurotrophic Factor Therapies for Neurodegenerative Diseases60%
see_also📖TGF-beta Signaling Therapies for Neurodegeneration60%
see_also📖UBE3A60%
see_also📖CREB3 Gene60%
see_also📖PINK1 — PTEN Induced Kinase 1 (PARK6)60%
see_also📖slc1a3 Gene60%
see_also📖TNFRSF1B Gene60%
see_also📖UBE3A Gene60%
see_also📖NRF2 Activator Therapy60%
see_also📖MAOA Gene60%
see_also📖NDUFV1 Gene60%
see_also📖PLEC Gene60%
mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
mentions🔬What are the mechanisms underlying astrocyte reactivity subt50%
mentions🔬What are the mechanisms underlying microglia-astrocyte cross50%
mentions🔬What are the mechanisms underlying neuroinflammation resolut50%
mentions🔬What are the mechanisms underlying mitochondrial transfer be50%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
mentions🔬Senescent cell clearance as neurodegeneration therapy50%
mentions🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%
mentions🧪SASP-Driven Aquaporin-4 Dysregulation50%
mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors50%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%
mentions🧪Complement C1q Mimetic Decoy Therapy50%
mentions🧪Circadian Clock-Autophagy Synchronization50%
mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor50%
mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri50%
mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming50%
mentions🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho50%
mentions🧪LRP1-Dependent Tau Uptake Disruption50%
mentions🧪SASP-Mediated Cholinergic Synapse Disruption50%
mentions🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism50%
mentions🧪Perforant Path Presynaptic Terminal Protection Strategy50%
mentions🧪Prefrontal sensory gating circuit restoration via PV interne50%
mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%
mentions🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration50%
mentions🧪Synaptic Vesicle Tau Capture Inhibition50%
mentions🧪Temporal TET2-Mediated Hydroxymethylation Cycling50%
mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%
mentions🧪TREM2-mediated microglial tau clearance enhancement50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Senescent cell clearance as neurodegeneration therapy50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🧪Temporal Decoupling via Circadian Clock Reset40%
related🧪Netrin-1 Gradient Restoration40%
related🧪Purinergic Signaling Polarization Control40%
related🧪Mitochondrial SPM Synthesis Platform Engineering40%
related🧪CX43 hemichannel engineering enables size-selective mitochon40%
related🧪RAB27A-dependent extracellular vesicle engineering for mitoc40%
related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m40%
related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation40%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi40%
related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho40%
related🧪Microglial Efferocytosis Enhancement via GPR32 Superagonists40%
related🧪Biorhythmic Interference via Controlled Sleep Oscillations40%
related🧪Quantum Coherence Disruption in Cellular Communication40%
related🧪Circadian Rhythm Entrainment of Reactive Astrocytes40%
related🧪Complement C1q Subtype Switching40%
related🧪Microglial Purinergic Reprogramming40%
related🧪Sphingolipid Metabolism Reprogramming40%
related🧪GAP43-mediated tunneling nanotube stabilization enhances neu40%
related🧪Extracellular Matrix Stiffness Modulation40%
related🧪Lipid Droplet Dynamics as Phenotype Switches40%
related🧪Circadian-Gated Maresin Biosynthesis Amplification40%
related🧪Blood-Brain Barrier SPM Shuttle System40%
related🧪Mitochondrial Transfer Pathway Enhancement40%
related🧪TFAM overexpression creates mitochondrial donor-recipient gr40%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization40%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th40%
related🧪Glial Glycocalyx Remodeling Therapy40%
related🧪Aquaporin-4 Polarization Rescue40%
related🧪Epigenetic Memory Erasure via TET2 Activation40%
related🧪Mechanosensitive Ion Channel Reprogramming40%
related🧪Synthetic Biology Rewiring via Orthogonal Receptors40%
related🧪Ephrin-B2/EphB4 Axis Manipulation40%
related🧪Phase-Separated Organelle Targeting40%
related🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution40%
related🧪Near-infrared light therapy stimulates COX4-dependent mitoch40%
related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia40%
related🧪Complement C1QA Spatial Gradient in Cortical Layers40%
related🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation40%
related🧪APOE Isoform Expression Across Glial Subtypes40%
related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro40%
related🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli40%
related🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK40%
related🧪SASP-Mediated Cholinergic Synapse Disruption40%
related🔬What are the mechanisms underlying neuroinflammation resolut40%
related🔬SPMs (resolvins, protectins, maresins) from omega-3s may pro40%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc40%
related🔬What are the mechanisms underlying mitochondrial transfer be40%
related🔬Mitochondrial transfer between astrocytes and neurons40%
related🔬PSP and CBD both involve 4R-tau but produce distinct neuropa40%
related🔬Senescent cell clearance as neurodegeneration therapy40%
related🔬Senescent cell clearance as neurodegeneration therapy40%
related🔬What are the mechanisms underlying microglia-astrocyte cross40%
related🔬Microglia activate astrocytes via IL-1alpha/TNF/C1q, and rea40%
related🔬What are the mechanisms underlying astrocyte reactivity subt40%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp24%